En­do sells in­ter­na­tion­al busi­ness for $84M

En­do is sell­ing its in­ter­na­tion­al phar­ma­ceu­ti­cals busi­ness to Knight Ther­a­peu­tics, a Mon­tre­al-based spe­cial­ty phar­ma com­pa­ny.

En­do will get $84 mil­lion up­front and could make an­oth­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER